RNA polymerase inhibitors (Rutgers University/Provid/Howard Hughes Medical Institute)

N/A

Report date: 2025/01/26 18:02:07
NME

Base Information

Drug NameRNA polymerase inhibitors (Rutgers University/Provid/Howard Hughes Medical Institute)
Drug Alias NameRNA polymerase inhibitors (Provid/Rutgers University/Howard University)
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Peptidomimetic
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHoward Hughes Medical InstituteProvid Pharmaceuticals IncRutgers University
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A